APOLLO BioWellness Inc (KOAN) is a company that, based on its 10-K filed June 10, 2025 for the fiscal year ended December 31, 2024, does not disclose an active revenue-generating business in the filing excerpts available. The filing reveals recurring operating losses, a working capital deficit of $2,150,975 as of December 31, 2023, and an accumulated deficit of $26,736,403 as of December 31, 2023. The auditor issued a going concern qualification. President and Secretary Jim Morrison received no salary, bonus, or equity compensation in FY2024 or FY2023. The balance sheet references advances to Pegasus Specialty Vehicles, LLC and multiple series of convertible notes payable, preferred stock, and derivative liabilities, suggesting a shell or development-stage capital structure. No product lines, revenue streams, customers, or operating segments are described in the excerpts provided.

Source: SEC 10-K, filed 2025-06-10

Industry: Services-Prepackaged Software Peers: CNBX Pharmaceuticals Inc Baudax Bio, Inc. Bespoke Extracts Inc NEXIEN BIOPHARMA, INC. Johnson & Johnson NEUROPATHIX, INC. GRI Bio Inc